EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46,349 | +217.3% | 51,679 | +317.5% | 0.02% | +200.0% |
| Q4 2022 | $14,609 | -80.0% | 12,379 | +7.4% | 0.01% | -77.1% |
| Q2 2022 | $73,000 | -16.1% | 11,527 | +6.5% | 0.04% | +9.4% |
| Q1 2022 | $87,000 | +50.0% | 10,827 | +4.6% | 0.03% | +68.4% |
| Q4 2021 | $58,000 | -14.7% | 10,352 | +2.7% | 0.02% | -24.0% |
| Q3 2021 | $68,000 | -17.1% | 10,077 | +0.5% | 0.02% | -24.2% |
| Q2 2021 | $82,000 | -15.5% | 10,027 | -6.8% | 0.03% | -19.5% |
| Q1 2021 | $97,000 | – | 10,763 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |